ipharmaservicesNov 23, 2022US FDA Withdrawals | News | Blenrep was withdrawn from the US market | iPharmaCenter
ipharmaservicesSep 11, 2022US FDA approved BMS Sotyktu (deucravacitinib) for moderate to severe plaque psoriasis |iPharmaCenter
ipharmaservicesAug 19, 2022bluebird bio's $2.8 million gene therapy Zynteglo received FDA nod for beta-thalassemia
ipharmaservicesJun 25, 2022BMS' Breyanzi was approved for relapsed or refractory LBCL | News | FDA | iPharmacenter
ipharmaservicesMay 30, 2022FDA approved two Opdivo based regimens as a 1L treatment for ESCC | FDA News | iPharmaCenter